Development fo a novel treatment for asthma: the identification of lead small molecule antagonists of the IL-13/IL-13 re [ 2004 - 2004 ]

Research Grant

Researchers: A/Pr Ian Street (Principal investigator) ,  Dr Keith Watson ,  Prof Douglas Hilton ,  Prof Jonathan Baell

Brief description In developed countries Asthma ranks among the most common chronic illnesses. Over two million Australians now have this condition and the cost to our community is estimated to be in excess of $720 million per annum. In 1996 researchers at The Walter and Eliza Hall Institute discovered a new member of the cytokine receptor family, IL-13Ra1, which further research has strongly implicated in the pathology of this disease. The main goal of the proposed research is to discover small molecule antagonists of IL-13Ra1 and to identify those suitable for development as novel asthma therapeutics.

Funding Amount $AUD 99,750.00

Funding Scheme NHMRC Development Grants

Notes Development Grant